SCHEMBL6160435

SCHEMBL6160435

CCOc1cc2ncnc(Cl)c2cc1OC.COc1cc2c(Cl)ncnc2cc1O

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 3/20 0.84
KDR P35968 10/20 0.47
RET P07949 10/20 0.47
KIF5B P33176 7/20 0.47
ALDH1A1 P00352 1/20 0.47
EGFR P00533 4/20 0.46
SRC P12931 1/20 0.46
FLT1 P17948 1/20 0.45
GAK O14976 1/20 0.45
RIPK2 O43353 1/20 0.45
STK10 O94804 1/20 0.45
FLT3 P36888 1/20 0.45
JAK3 P52333 1/20 0.45
AAK1 Q2M2I8 1/20 0.45
Q6ZSR9 Q6ZSR9 1/20 0.45
SLK Q9H2G2 1/20 0.45
IRAK4 Q9NWZ3 1/20 0.45
RPS6KA6 Q9UK32 1/20 0.45
ALK Q9UM73 1/20 0.45
LCK P06239 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30591048 0.92 ENPP1 (1.00) ENPP1KDRALDH1A1EGFRSRC
SCHEMBL1012109 0.92 ENPP1 (1.00) ENPP1KDRALDH1A1EGFRSRC
SCHEMBL1013282 0.92 ENPP1 (1.00) ENPP1KDRALDH1A1EGFRSRC
SCHEMBL30054610 0.89 ENPP1 (0.63) ENPP1KDRRETKIF5BEGFR
SCHEMBL296984 0.89 ENPP1 (0.63) ENPP1KDRRETKIF5BEGFR
SCHEMBL24037763 0.86 ENPP1 (0.68) ENPP1KDRRETKIF5BALDH1A1
SCHEMBL30032092 0.86 ENPP1 (0.63) ENPP1KDRRETKIF5BEGFR
SCHEMBL666884 0.86 ENPP1 (0.63) ENPP1KDRRETKIF5BEGFR
SCHEMBL1013257 0.86 ENPP1 (0.88) ENPP1ALDH1A1EGFR
Hydrochloric Acid SCHEMBL28108173 0.84 ENPP1 (0.61) ENPP1KDRRETKIF5BEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528925-A1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Astrazeneca AB (SE) 2005-05-11 EP disclosed
WO-2004004732-A1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2004-01-15 WO disclosed